losartan has been researched along with Adrenal Cortex Cancer in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takeda, Y | 1 |
| Usukura, M | 1 |
| Yoneda, T | 1 |
| Oda, N | 1 |
| Ito, Y | 1 |
| Mabuchi, H | 1 |
1 other study available for losartan and Adrenal Cortex Cancer
| Article | Year |
|---|---|
The expression of messenger RNA for ADP-ribosyl cyclase in aldosterone-producing adenomas.
Topics: Adenoma; ADP-ribosyl Cyclase; Adrenal Cortex Neoplasms; Aldosterone; Angiotensins; Case-Control Stud | 2005 |